Curriculum Vitae of Breffni Martin
Breffni Martin was educated at Cistercian College Roscrea and University College Dublin, where he graduated in Biology in 1983. He spent the next 20 years in the pharmaceutical industry in a variety of areas including the following:
-
US and international regulatory affairs
-
Licensing
-
FDA compliance and inspection
-
Technology transfer
-
Analytical science
-
Auditing
-
Validation
-
Writing (scientific/regulatory/medical/French-English translation)
-
Laboratory Information Systems (to support QC, pharm/tox, biological screening etc)
Professional Experience
Director
CanReg (Europe) Ltd Since January 2004
CanReg (Europe) is the European subsidiary of CanReg Inc , the largest regulatory services company in Canada. CanReg specialises in providing high-quality low-cost regulatory services for North America including the following:
-
Clinical trial applications
-
New Drug Applications/Submissions including the CTD
-
Notifiable changes and variations
-
Quality and compliance services
-
Regulatory services
-
Reimboursement
-
Training
Director
RegIntel Ltd 2003 - Present
Ireland
Founded RegIntel Limited, an Irish-based consultancy specialising in regulatory intelligence and licensing
Director Product Development, Business Development
IMS Health, IH Inc and Liquent Inc. 1997 - 2002
Paris, France
IDRAC is an on-line database of regulatory information covering the whole drug development lifecycle in over 30 countries. Breffni Martin managed content for the US and developed content for Japan, the UK, Ireland, Canada, Australia, Latin America, South East Asia, Scandinavia, Greece.
Most recently he created and launched the AdComm Bulletin, which covers human drug advisory committee meetings run by FDA and has been well received by industry.
Freelance Consultant
Paris, France, and USA 1995 - 1997
Clients included:
-
IBM Medical (telemedicine)
-
Notocord SA (pharm/tox software)
-
Biologie & Industrie (medical writing)
- Servier (medical writing)
- Pfizer (auditing)
Regulatory, Compliance Manager; Analytical Services Director
GSK
Singapore 1992 - 1995
Part of a multi-disciplinary team responsible for commissioning a $300 million multi-purpose manufacturing facility for supplying the US market, with specific responsibility for regulatory affairs, all analytical matters on site, validation (systems, software, analytical methodology), hiring and training a staff of more than 40 scientists.
API's for Imigran, Zofran, and Severent successfully commissioned for US and Japanese markets.
Medical and Promotional Writer
Hong Kong and SE Asia 1991
Clients included:
-
Medica Excerpta, HK Trade Development Council, Asian Sources (medical and promotional writing)
-
Concordia - paper recycling (completed an environmental impact assessment report)
Pharmaceutical Development Manager